Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Year: 2021
Type: article
Study design: Observational Study
Source: The Lancet
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Clalit Health Services
OpenAlex ID: W3210126657
